ProQR Therapeutics (PRQR) Other Non Operating Income (2017 - 2021)

ProQR Therapeutics has disclosed Other Non Operating Income across 5 years of filings, most recently posting $242933.2 for Q3 2021.

• Other Non Operating Income for Q3 2021 came in at $242933.2, up 181.56% year-over-year; the trailing twelve-month figure through Sep 2021 was -$172003.1 (up 67.77% YoY), and the FY2020 annual result was -$2.3 million, down 380.86% from the prior year.
• Other Non Operating Income came in at $242933.2 for Q3 2021 at ProQR Therapeutics, up from -$169802.3 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $242933.2 in Q3 2021 to a low of -$3.1 million in Q4 2017.
• The 5-year median for Other Non Operating Income is -$14.84 (2018), against an average of -$191066.5.
• Peak annual rise in Other Non Operating Income reached 42801.18% in 2019, while the deepest fall reached 589219.46% in 2019.
• ProQR Therapeutics' Other Non Operating Income stood at -$3.1 million in 2017, then jumped by 100.0% to -$14.84 in 2018, then slumped by 589219.46% to -$87444.1 in 2019, then slumped by 180.88% to -$245611.7 in 2020, then soared by 198.91% to $242933.2 in 2021.
• The last three Other Non Operating Income figures came in at $242933.2 (Q3 2021), -$169802.3 (Q2 2021), and $477.67 (Q1 2021), per Business Quant data.